A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
Beth Israel Deaconess Medical Center · Universidade de São Paulo · +1 more institution
Abstract
Several clinical studies on major depressive disorder (MDD) have shown that blood brain-derived neurotrophic factor (BDNF) - a factor used to index neuroplasticity - is associated with depression response; however, the results are mixed. The purpose of our study was to evaluate whether BDNF levels are correlated with improvement of depression. We performed a systematic review and meta-analysis of the literature, searching Medline, Cochrane Central, SciELO databases and reference lists from retrieved articles for clinical studies comparing mean BDNF blood levels in depressed patients pre- and post-antidepressant treatments or comparing depressed patients with healthy controls. Two reviewers independently…
Citation impact
- FWCI
- 16.51
- Percentile
- 100%
- References
- 52
Authors
3- ARAndré R. Brunoni
Beth Israel Deaconess Medical Center, Universidade de São Paulo, Berenson Allen Center for Noninvasive Brain Stimulation
- MLMariana Lopes
Beth Israel Deaconess Medical Center, Berenson Allen Center for Noninvasive Brain Stimulation
- FFFelipe FregniCorresponding
Beth Israel Deaconess Medical Center, Berenson Allen Center for Noninvasive Brain Stimulation
Topics & keywords
- Meta-analysis
- Depression (economics)
- Internal medicine
- Publication bias
- Strictly standardized mean difference
- Antidepressant
- Brain-derived neurotrophic factor
- Medicine